sellModerate cluster of 4
Miller Steve sold $1.1M of CPRX
Chief Op. & Scientific Officer at CATALYST PHARMACEUTICALS, INC.. 50,000 shares at an average of $21.93, traded Dec 10, 2024, filed Dec 11, 2024.
Warning score
40Value
$1.1M
50,000 shares
Holdings after
686,996
-7% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001161697-24-000505, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 9, 2024 | MOption exercise Common stock, par value $0.001 per share | +11,872 | - | - | 686,996 | Dec 11, 2024 |
| Dec 10, 2024 | MOption exercise Common stock, par value $0.001 per share | +50,000 | $4.01 | $201k | 736,996 | Dec 11, 2024 |
| Dec 10, 2024 | SOpen-market sale Common stock, par value $0.001 per share | -50,000 | $21.93 | $1.1M | 686,996 | Dec 11, 2024 |
| Dec 9, 2024 | MOption exercise Restricted Stock Unitsderivative | -11,872 | $0.00 | $0 | 1,837,176 | Dec 11, 2024 |
| Dec 10, 2024 | MOption exercise Options to purchase common stockderivative | -50,000 | $0.00 | $0 | 1,787,176 | Dec 11, 2024 |
Related signals
Other insiders at CATALYST PHARMACEUTICALS, INC. and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 29Weak | sell 5 | CPRX CATALYST PHARMACEUTICALS, INC. | Elsbernd Brian Chief Compliance/Legal Officer | $287k | 13,256 | |
| 51Moderate | sell 5 | CPRX CATALYST PHARMACEUTICALS, INC. | Harper Molly director | $385k | 17,500 | |
| 33Weak | sell 5 | CPRX CATALYST PHARMACEUTICALS, INC. | INGENITO GARY Chief Med. & Reg. Officer | $273k | 12,000 | |
| 47Moderate | sell 4 | CPRX CATALYST PHARMACEUTICALS, INC. | INGENITO GARY Chief Med. & Reg. Officer | $806k | 38,000 | |
| 40Moderate | sell 4 | CPRX CATALYST PHARMACEUTICALS, INC. | MCENANY PATRICK J director, other | $3.6M | 170,845 | |
| 40Moderate | sell 4 | CPRX CATALYST PHARMACEUTICALS, INC. | MCENANY PATRICK J director, other | $3.1M | 137,155 | |
| 38Weak | sell 2 | CPRX CATALYST PHARMACEUTICALS, INC. | MCENANY PATRICK J director, other | $12M | 492,000 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.